Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
letter
. 1998 Jul;106(7):A315–A317. doi: 10.1289/ehp.106-1533113

The importance of protocol design and data reporting to research on endocrine disruption.

J Ashby, J Odum
PMCID: PMC1533113  PMID: 9734998

Full text

PDF
A315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashby J., Elliott B. M. Reproducibility of endocrine disruption data. Regul Toxicol Pharmacol. 1997 Aug;26(1 Pt 1):94–95. doi: 10.1006/rtph.1997.1157. [DOI] [PubMed] [Google Scholar]
  2. Colerangle J. B., Roy D. Perturbation of cell cycle kinetics in the mammary gland by stilbene estrogen, diethylstilbestrol (DES). Cancer Lett. 1995 Jul 20;94(1):55–63. doi: 10.1016/0304-3835(95)03824-g. [DOI] [PubMed] [Google Scholar]
  3. Colerangle J. B., Roy D. Profound effects of the weak environmental estrogen-like chemical bisphenol A on the growth of the mammary gland of Noble rats. J Steroid Biochem Mol Biol. 1997 Jan;60(1-2):153–160. doi: 10.1016/s0960-0760(96)00130-6. [DOI] [PubMed] [Google Scholar]
  4. Foley J., Ton T., Maronpot R., Butterworth B., Goldsworthy T. L. Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats. Environ Health Perspect. 1993 Dec;101 (Suppl 5):199–205. doi: 10.1289/ehp.93101s5199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lee P. C., Lee W. In vivo estrogenic action of nonylphenol in immature female rats. Bull Environ Contam Toxicol. 1996 Sep;57(3):341–348. doi: 10.1007/s001289900196. [DOI] [PubMed] [Google Scholar]
  6. McLachlan J. A. Synergistic effect of environmental estrogens: report withdrawn. Science. 1997 Jul 25;277(5325):462–463. doi: 10.1126/science.277.5325.459d. [DOI] [PubMed] [Google Scholar]
  7. Nagel S. C., vom Saal F. S., Thayer K. A., Dhar M. G., Boechler M., Welshons W. V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect. 1997 Jan;105(1):70–76. doi: 10.1289/ehp.9710570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Odum J., Lefevre P. A., Tittensor S., Paton D., Routledge E. J., Beresford N. A., Sumpter J. P., Ashby J. The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. Regul Toxicol Pharmacol. 1997 Apr;25(2):176–188. doi: 10.1006/rtph.1997.1100. [DOI] [PubMed] [Google Scholar]
  9. vom Saal F. S., Timms B. G., Montano M. M., Palanza P., Thayer K. A., Nagel S. C., Dhar M. D., Ganjam V. K., Parmigiani S., Welshons W. V. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):2056–2061. doi: 10.1073/pnas.94.5.2056. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES